Tuesday 7th September, 2010 | 4:20 pm
Home
|
Sitemap
|
Contact us
Stock Quote
 |
Press Releases
 |
Financial Reports
 |
Electronic IR Package
 |
Site Search:
Products
Technologies
Contact
Products and Tecnologies
Products
Technologies
Our Company
History
Mission and Vision
Growth Strategy
Management Team
Board of Direction
Corporate Governance
Investor Relations
Stock Quote
Press releases
Financial Reports
Analysts
Webcast
Q4 Announcement
Home
GHRH Phase II Final Results
Fentanyl TAIFUN Phase IIb extension arm results
Q1 Earnings Announcement
Q2 Earnings Announcement
Akela Pharma, name change and corporate update
Media
Electronic IR Package
Business Units
LAB International
Pharma Form
Contact Us
Headquarters
Media and Investors
Business Units
FAQ
General
Media
Contact
Home
::
Our Company
::
Investor Relations
::
Products and Technologies
::
Business Units
::
Contact us
::
Site map
::
FAQ
Copyright 2007 © Akela Pharma